Automated adherent human cell culture (mesenchymal stem cells).

Human cell culture processes developed at research laboratory scale need to be translated to large-scale production processes to achieve commercial application to a large market. To allow this transition of scale with consistent process performance and control of costs, it will be necessary to reduce manual processing and increase automation. There are a number of commercially available platforms that will reduce manual process intervention and improve process control for different culture formats. However, in many human cell-based applications, there is currently a need to remain close to the development format, usually adherent culture on cell culture plastic or matrix-coated wells or flasks due to deterioration of cell quality in other environments, such as suspension. This chapter presents an example method for adherent automated human stem cell culture using a specific automated flask handling platform, the CompacT SelecT.

[1]  Matthias Schieker,et al.  Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing , 2009, Journal of anatomy.

[2]  David J. Williams,et al.  Human cell culture process capability: a comparison of manual and automated production , 2009, Journal of tissue engineering and regenerative medicine.

[3]  D J Williams,et al.  Application of process quality engineering techniques to improve the understanding of the in vitro processing of stem cells for therapeutic use. , 2008, Journal of biotechnology.

[4]  S. Chandran,et al.  Automated Mechanical Passaging: A Novel and Efficient Method for Human Embryonic Stem Cell Expansion , 2006, Stem cells.

[5]  Oliver Brüstle,et al.  Automated maintenance of embryonic stem cell cultures , 2007, Biotechnology and bioengineering.

[6]  J. Clemente,et al.  Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. , 2010, Journal of biotechnology.

[7]  David J. Williams,et al.  Automated, scalable culture of human embryonic stem cells in feeder‐free conditions , 2009, Biotechnology and bioengineering.

[8]  R. J. Thomas,et al.  Automated, serum-free production of CTX0E03: a therapeutic clinical grade human neural stem cell line , 2009, Biotechnology Letters.

[9]  S. Reuveny,et al.  Long-term microcarrier suspension cultures of human embryonic stem cells. , 2009, Stem cell research.